Skip to main content
DYN
NASDAQ Life Sciences

FDA Accepts Dyne's BLA for DMD Drug, Grants Priority Review with Jan 2027 PDUFA

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$23.95
Mkt Cap
$3.925B
52W Low
$8.88
52W High
$25
52W Position info
170% above low
Off High info
4.2% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

DYN has more than doubled off its 52-week low of $8.88.

Summary

The FDA accepted Dyne's BLA for z-rostudirsen in Duchenne muscular dystrophy and granted Priority Review, setting a PDUFA date of January 21, 2027. This follows the BLA submission in May and full enrollment of the registrational cohort in June. Priority Review signals the FDA sees this as a potential significant advance, and the company expects a U.S. launch in Q1 2027 if approved. With shares near a 52-week high, the market has been pricing in regulatory progress, but the official acceptance and timeline remove uncertainty and bring a near-term catalyst into focus.

At the time of this announcement, DYN was trading at $23.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $8.88 to $25.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

DYN - Latest Insights

DYN
Nov 05, 2026, 7:25 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.63
Real-time Price: $17.15 info
Change: -$1.48 (-8%) info
Market Cap: $3.242B info
DYN
Sep 29, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.78
Real-time Price: $17.15 info
Change: +$1.37 (+9%) info
Market Cap: $3.242B info
DYN
Sep 29, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $15.78
Real-time Price: $17.15 info
Change: +$1.37 (+9%) info
Market Cap: $3.242B info
DYN
Aug 17, 2026, 5:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $26.15
Real-time Price: $17.15 info
Change: -$9.00 (-34%) info
Market Cap: $3.242B info
DYN
Aug 14, 2026, 5:47 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $25.94
Real-time Price: $17.15 info
Change: -$8.79 (-34%) info
Market Cap: $3.242B info